Literature DB >> 21377730

Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.

Zsófia Nagy1, Béla Kajtár, Pál Jáksó, Mariann Dávid, Szabolcs Kosztolányi, Judit Hermesz, László Kereskai, László Pajor, Donát Alpár.   

Abstract

Bone marrow specimens from 185 patients with plasma cell disorders (PCD) were investigated by fluorescence in situ hybridization (FISH) in order to determine the temporal sequence of cytogenetic aberrations. In 25 cases combined FISH analysis has also been performed at single cell level. Clonal evolution was observed in 16% of cases. The Δ13 was preceded by t(4;14)(p16;q32) and t(14;16)(q32;q23) translocations. Deletion of p53 gene was a secondary aberration compared to Δ13 and t(11;14)(q13;q32) translocation. In 22% of all cases with recurrent IGH translocation, this aberration was presented only in a subset of purified plasma cells questioning its initiating role.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377730     DOI: 10.1016/j.leukres.2011.02.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.

Authors:  Martin Schmidt-Hieber; María Laura Gutiérrez; Martin Pérez-Andrés; Bruno Paiva; Ana Rasillo; Maria Dolores Tabernero; José Maria Sayagués; Antonio Lopez; Paloma Bárcena; María Luz Sanchez; Norma C Gutiérrez; Jesus F San Miguel; Alberto Orfao
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

2.  Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH.

Authors:  Yuting Yan; Xiaoqi Qin; Jiahui Liu; Huishou Fan; Wenqiang Yan; Lanting Liu; Chenxing Du; Zhen Yu; Yan Xu; Mu Hao; Shuhui Deng; Weiwei Sui; Rui Lyu; Wei Liu; Qi Wang; Dehui Zou; Linping Hu; Jianxiang Wang; Yu-Tzu Tai; Kenneth C Anderson; Lei Zhang; Tao Cheng; Anders Zetterberg; Nikhil C Munshi; Lugui Qiu; Gang An
Journal:  Blood Adv       Date:  2022-01-25

3.  Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.

Authors:  Charlotte Pawlyn; Lorenzo Melchor; Alex Murison; Christopher P Wardell; Annamaria Brioli; Eileen M Boyle; Martin F Kaiser; Brian A Walker; Dil B Begum; Nasrin B Dahir; Paula Proszek; Walter M Gregory; Mark T Drayson; Graham H Jackson; Fiona M Ross; Faith E Davies; Gareth J Morgan
Journal:  Blood       Date:  2014-11-26       Impact factor: 25.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.